bluebird bio, Inc.
USD4.97
+0.00 (+0.00%)
CEO
Andrew Obenshain
IPO Date
2013-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.97
Prev. Close
$4.97
Day Low
$4.97
Day High
$4.97
52W Low
$3.20
52W High
$28.60
Market Cap
$0.05B
Volume
1.25M
| -9.3 |
| 31 Dec 2022 | FY | -180.2% | -6403.7% | -117.3% | -41.5% | 1.87 | 1.27 | -47.2 |
| 31 Dec 2021 | FY | -961.1% | -22375.2% | -218.9% | -138.0% | 0.24 | 2.20 | -16.8 |
| 31 Dec 2020 | FY | 97.8% | -246.8% | -45.7% | -34.7% | 0.07 | 5.97 | -56.3 |
| 31 Dec 2019 | FY | 93.3% | -1767.5% | -61.4% | -45.7% | 0.15 | 5.15 | -79.4 |
| 31 Dec 2018 | FY | 98.4% | -1018.0% | -29.5% | -24.8% | 0.08 | 9.69 | -120.3 |
| 31 Dec 2017 | FY | 95.7% | -947.4% | -20.7% | -17.7% | 0.10 | 16.88 | -299.1 |
| 31 Dec 2016 | FY | -3227.0% | -4281.2% | -30.3% | -23.6% | 0.14 | 9.72 | -113.0 |
| 31 Dec 2015 | FY | -778.9% | -1184.6% | -19.6% | -16.6% | 0.07 | 12.98 | -172.8 |
| -4.7 |
| 30 Sept 2024 | Q3 | -11.0% | -573.0% | 1051.0% | -13.1% | -63.09 | 0.51 | -2.7 |
| 30 Jun 2024 | Q2 | -79.8% | -505.5% | -153.6% | -14.9% | 7.37 | 0.68 | -3.8 |
| 31 Mar 2024 | Q1 | -39.3% | -375.8% | -53.3% | -11.1% | 3.16 | 0.93 | -5.7 |
| 31 Dec 2023 | Q4 | -23.0% | -1129.9% | -45.5% | -14.3% | 1.70 | 1.41 | -5.6 |
| 30 Sept 2023 | Q3 | 11.6% | -578.8% | -32.2% | -11.7% | 1.36 | 1.55 | -15.1 |
| 30 Jun 2023 | Q2 | -38.8% | -1058.2% | -25.2% | -11.0% | 1.06 | 2.13 | -16.1 |
| 31 Mar 2023 | Q1 | -41.8% | 1429.8% | 9.6% | 4.9% | 0.77 | 3.03 | 33.3 |
| 31 Dec 2022 | Q4 | 64.5% | 51987.1% | 16.4% | 5.8% | 1.43 | 1.56 | 91.4 |